:

Natália Marcéli Stefanes1,2, Lisandra de Oliveira Silva1,2, Laura Otto Walter1,2

  • 1Experimental Oncology and Hemopathies Laboratory, Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianópolis, 88040-900, SC, Brazil.

概括

二甲基二甲基碳酸盐三水合物 (DETC) 显示出作为治疗血液性恶性瘤的新药的潜力. 它对白血病和淋巴瘤细胞具有有希望的细胞毒性,具有高选择性和有利的类似药物的特性.